{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:19:32Z","timestamp":1791929972063,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Evidence suggests a possible link between Autism spectrum disorder and gut permeability, specifically as indicated by serum zonulin levels. However, limited studies examine this connection to symptom severity, especially in Egypt. Assessing serum zonulin level in children with autism and its relation to the severity of symptoms. In Mansoura University Hospital\u2019s pediatric psychiatry outpatient clinics, case-control research was carried out with children with Autism diagnoses and age- and gender-matched typically developing controls. The Childhood Autism Rating Scale was used to gauge the severity of the symptoms, and the Enzyme-Linked Immunosorbent Assay (ELISA) was used to detect serum zonulin levels. Serum zonulin levels were considerably higher in children with Autism than in the control group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Additionally, there was a positive correlation between higher zonulin levels and the degree of autism symptoms as determined by CARS scores (r\u2009=\u2009X, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Children with severe Autism had the highest zonulin levels, according to subgroup analysis, which suggests a possible connection between gut permeability and the intensity of symptoms. This study emphasizes how serum zonulin may serve as a biomarker for intestinal permeability in kids with Autism and how it may be related to the intensity of symptoms. These results highlight the need for more investigation into the gut-brain axis as a potential therapeutic target for Autism. Addressing gut permeability may provide new ways to lessen the intensity of symptoms and enhance results for children with Autism.<\/jats:p>","DOI":"10.1038\/s41598-025-11420-0","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:36:21Z","timestamp":1753875381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Serum zonulin level in autistic children and its relation to severity of symptoms a case-control study"],"prefix":"10.1038","volume":"15","author":[{"given":"Hassan Mohammed","family":"Sonbol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Salah","family":"Abdelmawgoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora Marzouk","family":"El-kady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Sameh","family":"Abdelhay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosam Eldin","family":"Abdel Tawab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"issue":"3","key":"11420_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.pcl.2020.02.007","volume":"67","author":"T Kodak","year":"2020","unstructured":"Kodak, T. & Bergmann, S. Autism spectrum disorder. Pediatr. Clin. N. Am. 67 (3), 525\u2013535. https:\/\/doi.org\/10.1016\/j.pcl.2020.02.007 (2020).","journal-title":"Pediatr. Clin. North. Am."},{"issue":"12","key":"11420_CR2","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1001\/jama.2017.12141","volume":"318","author":"S Sandin","year":"2017","unstructured":"Sandin, S. et al. The heritability of autism spectrum disorder. JAMA 318 (12), 1182\u20131184 (2017).","journal-title":"JAMA"},{"issue":"11","key":"11420_CR3","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00702-020-02188-w","volume":"127","author":"A Imamura","year":"2020","unstructured":"Imamura, A. et al. Genetic and environmental factors of schizophrenia and autism spectrum disorder: Insights from twin studies. J. Neural Transm. 127 (11), 1501\u20131515 (2020).","journal-title":"J. Neural Transm"},{"issue":"8","key":"11420_CR4","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s10803-014-2081-2","volume":"44","author":"TW Frazier","year":"2014","unstructured":"Frazier, T. W. et al. A twin study of heritable and shared environmental contributions to autism. J. Autism Dev. Disord. 44 (8), 2013\u20132025 (2014).","journal-title":"J. Autism Dev. Disord"},{"key":"11420_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bbr.2017.04.038","volume":"331","author":"K Yenkoyan","year":"2017","unstructured":"Yenkoyan, K., Grigoryan, A., Fereshetyan, K. & Yepremyan, D. Advances in understanding the pathophysiology of autism spectrum disorders. Behav. Brain Res. 331, 92\u2013101. https:\/\/doi.org\/10.1016\/j.bbr.2017.04.038 (2017).","journal-title":"Behav. Brain Res."},{"issue":"3","key":"11420_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.chc.2020.02.005","volume":"29","author":"M Madra","year":"2020","unstructured":"Madra, M., Ringel, R. & Margolis, K. G. Gastrointestinal issues and autism spectrum disorder. Child. Adolesc. Psychiatr. Clin. N. Am. 29 (3), 501\u2013513 (2020).","journal-title":"Child. Adolesc. Psychiatr Clin. N Am."},{"issue":"10","key":"11420_CR7","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1124\/dmd.115.063826","volume":"43","author":"CS Rosenfeld","year":"2015","unstructured":"Rosenfeld, C. S. Microbiome disturbances and autism spectrum disorders. Drug Metab. Dispos. 43 (10), 1557\u20131571. https:\/\/doi.org\/10.1124\/dmd.115.063826 (2015).","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"11420_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1177\/1362361318757564","volume":"23","author":"V Thulasi","year":"2018","unstructured":"Thulasi, V., Steer, R. A., Monteiro, I. M. & Ming, X. Overall severities of gastrointestinal symptoms in pediatric outpatients with and without autism spectrum disorder. Autism 23 (2), 524\u2013530. https:\/\/doi.org\/10.1177\/1362361318757564 (2018).","journal-title":"Autism"},{"issue":"1","key":"11420_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/aur.1854","volume":"11","author":"C Holingue","year":"2018","unstructured":"Holingue, C., Newill, C., Lee, L. C., Pasricha, P. J. & Daniele Fallin, M. Gastrointestinal symptoms in autism spectrum disorder: A review of the literature on ascertainment and prevalence. Autism Res. 11 (1), 24\u201336 (2018).","journal-title":"Autism Res."},{"issue":"5","key":"11420_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s10803-013-1973-x","volume":"44","author":"V Chaidez","year":"2014","unstructured":"Chaidez, V., Hansen, R. L. & Hertz-Picciotto, I. Gastrointestinal problems in children with autism, developmental delays or typical development. J. Autism Dev. Disord. 44 (5), 1117\u20131127 (2014).","journal-title":"J. Autism Dev. Disord"},{"issue":"7","key":"11420_CR11","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/nu14071471","volume":"14","author":"G Leader","year":"2022","unstructured":"Leader, G. et al. Gastrointestinal symptoms in autism spectrum disorder: A systematic review. Nutrients 14 (7), 1471 (2022).","journal-title":"Nutrients"},{"key":"11420_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.physbeh.2014.10.033","volume":"138","author":"A Tomova","year":"2015","unstructured":"Tomova, A. et al. Gastrointestinal microbiota in children with autism in Slovakia. Physiol. Behav. 138, 179\u2013187. https:\/\/doi.org\/10.1016\/j.physbeh.2014.10.033 (2015).","journal-title":"Physiol. Behav."},{"key":"11420_CR13","doi-asserted-by":"publisher","first-page":"1000419","DOI":"10.3389\/fmicb.2022.1000419","volume":"13","author":"W Deng","year":"2022","unstructured":"Deng, W. et al. Gastrointestinal symptoms have a minor impact on autism spectrum disorder and associations with gut microbiota and short-chain fatty acids. Front. Microbiol. 13, 1000419 (2022).","journal-title":"Front. Microbiol."},{"issue":"1","key":"11420_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41398-019-0389-6","volume":"9","author":"F Liu","year":"2019","unstructured":"Liu, F. et al. Altered composition and function of intestinal microbiota in autism spectrum disorders: A systematic review. Transl. Psychiatry. 9 (1), 43 (2019).","journal-title":"Transl Psychiatry"},{"issue":"9","key":"11420_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","volume":"33","author":"NR Shin","year":"2015","unstructured":"Shin, N. R., Whon, T. W. & Bae, J. W. Proteobacteria: Microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 33 (9), 496\u2013503. https:\/\/doi.org\/10.1016\/j.tibtech.2015.06.011 (2015).","journal-title":"Trends Biotechnol."},{"issue":"4","key":"11420_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.neuint.2006.12.013","volume":"50","author":"Y Zhu","year":"2007","unstructured":"Zhu, Y., Carvey, P. M. & Ling, Z. Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide. Neurochem. Int. 50 (4), 671\u2013680 (2007).","journal-title":"Neurochem Int."},{"issue":"3","key":"11420_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pathophys.2006.05.007","volume":"13","author":"A Chauhan","year":"2006","unstructured":"Chauhan, A. & Chauhan, V. Oxidative stress in autism. Pathophysiology 13 (3), 171\u2013181. https:\/\/doi.org\/10.1016\/j.pathophys.2006.05.007 (2006).","journal-title":"Pathophysiology"},{"issue":"8","key":"11420_CR18","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.3390\/ijms19082251","volume":"19","author":"G Fowlie","year":"2018","unstructured":"Fowlie, G., Cohen, N. & Ming, X. The perturbance of microbiome and gut-brain axis in autism spectrum disorders. Int. J. Mol. Sci. 19 (8), 2251 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"11420_CR19","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3390\/nu15071620","volume":"15","author":"VN Dargenio","year":"2023","unstructured":"Dargenio, V. N. et al. Intestinal barrier dysfunction and Microbiota-Gut-Brain axis: Possible implications in the pathogenesis and treatment of autism spectrum disorder. Nutrients 15 (7), 1620 (2023).","journal-title":"Nutrients"},{"issue":"4","key":"11420_CR20","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3390\/ijms22041623","volume":"22","author":"D Banfi","year":"2021","unstructured":"Banfi, D. et al. Impact of microbial metabolites on microbiota-gut-brain axis in inflammatory bowel disease. Int. J. Mol. Sci. 22 (4), 1623 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"11420_CR21","doi-asserted-by":"publisher","first-page":"20220354","DOI":"10.1515\/tnsci-2022-0354","volume":"15","author":"RM Bin-Khattaf","year":"2024","unstructured":"Bin-Khattaf, R. M. et al. In a rodent model of autism, probiotics decrease gut leakiness in relation to gene expression of GABA receptors: Emphasize how crucial the gut-brain axis. Transl. Neurosci. 15 (1), 20220354 (2024).","journal-title":"Transl Neurosci."},{"issue":"5","key":"11420_CR22","doi-asserted-by":"publisher","first-page":"e27321","DOI":"10.4161\/tisb.27321","volume":"1","author":"T Vanuytsel","year":"2013","unstructured":"Vanuytsel, T., Vermeire, S. & Cleynen, I. The role of haptoglobin and its related protein, zonulin, in inflammatory bowel disease. Tissue Barriers. 1 (5), e27321\u2013e27321 (2013).","journal-title":"Tissue Barriers"},{"issue":"1","key":"11420_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1152\/physrev.00003.2008","volume":"91","author":"A Fasano","year":"2011","unstructured":"Fasano, A. Zonulin and its regulation of intestinal barrier function: The biological door to inflammation, autoimmunity, and Cancer. Physiol. Rev. 91 (1), 151\u2013175. https:\/\/doi.org\/10.1152\/physrev.00003.2008 (2011).","journal-title":"Physiol. Rev."},{"issue":"1","key":"11420_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.schres.2014.06.027","volume":"176","author":"EG Severance","year":"2016","unstructured":"Severance, E. G., Yolken, R. H. & Eaton, W. W. Autoimmune diseases, Gastrointestinal disorders and the Microbiome in schizophrenia: More than a gut feeling. Schizophr. Res. 176 (1), 23\u201335 (2016).","journal-title":"Schizophr Res."},{"key":"11420_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jpeds.2017.04.004","volume":"188","author":"E Esnafoglu","year":"2017","unstructured":"Esnafoglu, E. et al. Increased serum Zonulin levels as an intestinal permeability marker in autistic subjects. J. Pediatr. 188, 240\u2013244. https:\/\/doi.org\/10.1016\/j.jpeds.2017.04.004 (2017).","journal-title":"J. Pediatr."},{"issue":"2","key":"11420_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1089\/jmf.2017.0069","volume":"21","author":"J J\u00f3zefczuk","year":"2018","unstructured":"J\u00f3zefczuk, J. et al. The occurrence of antibodies against gluten in children with autism spectrum disorders does not correlate with serological markers of impaired intestinal permeability. J. Med. Food. 21 (2), 181\u2013187. https:\/\/doi.org\/10.1089\/jmf.2017.0069 (2018).","journal-title":"J. Med. Food"},{"key":"11420_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.comppsych.2018.10.006","volume":"87","author":"G \u00d6zyurt","year":"2018","unstructured":"\u00d6zyurt, G. et al. Increased Zonulin is associated with hyperactivity and social dysfunctions in children with attention deficit hyperactivity disorder. Compr. Psychiatry. 87, 138\u2013142. https:\/\/doi.org\/10.1016\/j.comppsych.2018.10.006 (2018).","journal-title":"Compr. Psychiatry"},{"key":"11420_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcae175.772","author":"RM Elhossiny","year":"2024","unstructured":"Elhossiny, R. M., Nawar, H. K., Abdelhamid, D. H., AbdelAziz, A. W. & Abdel Raouf, B. M. Effect of vitamin A supplement on serotonin level and severity of autistic symptoms in autistic children. QJM Int. J. Med. https:\/\/doi.org\/10.1093\/qjmed\/hcae175.772 (2024).","journal-title":"QJM Int. J. Med."},{"key":"11420_CR29","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (Diagnostic Stat Man Ment Disord, 2022).","DOI":"10.1176\/appi.books.9780890425787"},{"issue":"5","key":"11420_CR30","first-page":"250","volume":"22","author":"H Kara","year":"2021","unstructured":"Kara, H., A\u00e7\u0131kel, S. B., \u00c7etinkaya, M. & Tuncer, S. \u00c7. Serum Zonulin levels are higher among children with autism spectrum disorders and correlated with social impairment. Anadolu Psikiyatr. Derg. 22 (5), 250\u2013256 (2021).","journal-title":"Anadolu Psikiyatr Derg"},{"issue":"03","key":"11420_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4088\/jcp.09m05305whi","volume":"71","author":"DV Sheehan","year":"2010","unstructured":"Sheehan, D. V. et al. Reliability and validity of the Mini international neuropsychiatric interview for children and adolescents (MINI-KID). J. Clin. Psychiatry. 71 (03), 313\u2013326. https:\/\/doi.org\/10.4088\/jcp.09m05305whi (2010).","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"11420_CR32","first-page":"734","volume":"30","author":"SSA El-Ella","year":"2017","unstructured":"El-Ella, S. S. A., Tawfik, M. A. M., El-Fotoh, W. M. A. & Gomma, A. A. K. B. Assessment of intellectual development in preschool children in West of menoufia governorate, Egypt. Menoufia Med. J. 30 (3), 734 (2017).","journal-title":"Menoufia Med. J."},{"key":"11420_CR33","doi-asserted-by":"publisher","unstructured":"Schopler, E., Reichler, R. J., DeVellis, R. F. & Daly, K. Childhood Autism Rating Scale [Internet]. PsycTESTS Dataset. American Psychological Association (APA); (1980). https:\/\/doi.org\/10.1037\/t49458-000","DOI":"10.1037\/t49458-000"},{"key":"11420_CR34","doi-asserted-by":"publisher","unstructured":"Alotaibi, B. & Alotaibi, A. Exploratory and confirmatory factor analyses of the Arabic version of the Childhood Autism Rating Scale. Res. Autism Spectr. Disord. 86(July 2020), 101827 (2021). https:\/\/doi.org\/10.1016\/j.rasd.2021.101827","DOI":"10.1016\/j.rasd.2021.101827"},{"issue":"4","key":"11420_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/0734282908317116","volume":"26","author":"JM Montgomery","year":"2008","unstructured":"Montgomery, J. M., Newton, B. & Smith, C. Test review: gilliam, J. (2006). GARS-2: Gilliam autism rating Scale\u2014Second edition. Austin, TX: PRO-ED. J. Psychoeduc Assess. 26 (4), 395\u2013401. https:\/\/doi.org\/10.1177\/0734282908317116 (2008).","journal-title":"J. Psychoeduc Assess."},{"key":"11420_CR36","unstructured":"Mohammad, S. A. Psychometric properties of Jordanian version of the Gilliam autism rating scale -Third edition based on DSM-5. 48(3), 355\u2013372. (2021)."},{"issue":"2","key":"11420_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/bf01535722","volume":"33","author":"J Svedlund","year":"1988","unstructured":"Svedlund, J., Sj\u00f6din, I. & Dotevall, G. GSRS?A clinical rating scale for Gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig. Dis. Sci. 33 (2), 129\u2013134. https:\/\/doi.org\/10.1007\/bf01535722 (1988).","journal-title":"Dig. Dis. Sci."},{"issue":"5","key":"11420_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nmo.13003","volume":"29","author":"AD Lee","year":"2017","unstructured":"Lee, A. D. et al. Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population. Neurogastroenterol. Motil. 29 (5), 1\u20139 (2017).","journal-title":"Neurogastroenterol Motil."},{"issue":"1","key":"11420_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-021-01814-4","volume":"16","author":"Y Ding","year":"2021","unstructured":"Ding, Y. et al. Assessment of tuberous sclerosis-associated neuropsychiatric disorders using the MINI-KID tool: A pediatric case\u2013control study. Orphanet J. Rare Dis. 16 (1), 1\u20137 (2021).","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"11420_CR40","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1007\/s10803-019-04090-1","volume":"49","author":"MG Mosner","year":"2019","unstructured":"Mosner, M. G. et al. Rates of Co-occurring psychiatric disorders in autism spectrum disorder using the Mini international neuropsychiatric interview. J. Autism Dev. Disord. 49 (9), 3819\u20133832. https:\/\/doi.org\/10.1007\/s10803-019-04090-1 (2019).","journal-title":"J. Autism Dev. Disord"},{"issue":"8","key":"11420_CR41","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1073\/pnas.0500178102","volume":"102","author":"T Watts","year":"2005","unstructured":"Watts, T. et al. Role of the intestinal tight junction modulator Zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc. Natl. Acad. Sci. U S A. 102 (8), 2916\u20132921 (2005).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"9","key":"11420_CR42","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/j.1651-2227.1996.tb14220.x","volume":"85","author":"P D\u2019Eufemia","year":"1996","unstructured":"D\u2019Eufemia, P. et al. Abnormal intestinal permeability in children with autism. Acta Paediatr. 85 (9), 1076\u20131079. https:\/\/doi.org\/10.1111\/j.1651-2227.1996.tb14220.x (1996).","journal-title":"Acta Paediatr."},{"issue":"6","key":"11420_CR43","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1007\/s10803-007-0482-1","volume":"38","author":"MA Robertson","year":"2008","unstructured":"Robertson, M. A. et al. Intestinal permeability and Glucagon-like peptide-2 in children with autism: A controlled pilot study. J. Autism Dev. Disord. 38 (6), 1066\u20131071. https:\/\/doi.org\/10.1007\/s10803-007-0482-1 (2008).","journal-title":"J. Autism Dev. Disord"},{"issue":"1","key":"11420_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s43163-022-00270-6","volume":"38","author":"E Ahmed","year":"2022","unstructured":"Ahmed, E., Mansour, A., Amer, A., Barakat, T. & Baz, H. Screening of gastrointestinal symptoms and Celiac disease in children with autism spectrum disorder. Egypt. J. Otolaryngol. 38 (1), 81 (2022).","journal-title":"Egypt. J. Otolaryngol."},{"issue":"1","key":"11420_CR45","doi-asserted-by":"publisher","first-page":"e0210064","DOI":"10.1371\/journal.pone.0210064","volume":"14","author":"MR Sanctuary","year":"2019","unstructured":"Sanctuary, M. R. et al. Pilot study of probiotic\/colostrum supplementation on gut function in children with autism and gastrointestinal symptoms. PLoS One. 14 (1), e0210064 (2019).","journal-title":"PLoS One"},{"issue":"1","key":"11420_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/bf01537742","volume":"1","author":"MS Goodwin","year":"1971","unstructured":"Goodwin, M. S., Goodwin, T. C. & Cowen, M. A. Malabsorption and cerebral dysfunction: A multivariate and comparative study of autistic children. J. Autism Child. Schizophr. 1 (1), 48\u201362. https:\/\/doi.org\/10.1007\/bf01537742 (1971).","journal-title":"J. Autism Child. Schizophr"},{"key":"11420_CR47","doi-asserted-by":"crossref","unstructured":"Elder, J. H., Kreider, C. M., Schaefer, N. M. & de Laosa, M. B. A review of gluten-and casein-free diets for treatment of autism: 2005\u20132015. Nutr. Diet. Suppl. ;87\u2013101. (2015).","DOI":"10.2147\/NDS.S74718"},{"issue":"3","key":"11420_CR48","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.rasd.2009.10.008","volume":"4","author":"A Mulloy","year":"2010","unstructured":"Mulloy, A. et al. Gluten-free and casein-free diets in the treatment of autism spectrum disorders: A systematic review. Res. Autism Spectr. Disord. 4 (3), 328\u2013339 (2010).","journal-title":"Res. Autism Spectr. Disord"},{"issue":"10","key":"11420_CR49","doi-asserted-by":"publisher","first-page":"8144","DOI":"10.1007\/s12035-024-04099-3","volume":"61","author":"G Bj\u00f8rklund","year":"2024","unstructured":"Bj\u00f8rklund, G. et al. The role of dietary peptides gluten and casein in the development of autism spectrum disorder: Biochemical perspectives. Mol. Neurobiol. 61 (10), 8144\u20138155 (2024).","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"11420_CR50","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.2337\/db05-1593","volume":"55","author":"A Sapone","year":"2006","unstructured":"Sapone, A. et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 55 (5), 1443\u20131449. https:\/\/doi.org\/10.2337\/db05-1593 (2006).","journal-title":"Diabetes"},{"issue":"4","key":"11420_CR51","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s10620-009-0813-5","volume":"55","author":"DR Duerksen","year":"2009","unstructured":"Duerksen, D. R., Wilhelm-Boyles, C., Veitch, R., Kryszak, D. & Parry, D. M. A comparison of antibody testing, permeability testing, and Zonulin levels with Small-Bowel biopsy in Celiac disease patients on a Gluten-Free diet. Dig. Dis. Sci. 55 (4), 1026\u20131031. https:\/\/doi.org\/10.1007\/s10620-009-0813-5 (2009).","journal-title":"Dig. Dis. Sci."},{"issue":"4","key":"11420_CR52","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/mpg.0b013e3181dcc4a5","volume":"51","author":"L de Magistris","year":"2010","unstructured":"de Magistris, L. et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their First-degree relatives. J. Pediatr. Gastroenterol. Nutr. 51 (4), 418\u2013424. https:\/\/doi.org\/10.1097\/mpg.0b013e3181dcc4a5 (2010).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"1","key":"11420_CR53","first-page":"62","volume":"1","author":"D Dosti","year":"2023","unstructured":"Dosti, D., Uzunoska, Z. & Knights, V. A. Food intolerance in autism spectrum disorders. Horiz.-Int. Sci. J. 1 (1), 62\u201376 (2023).","journal-title":"Horizons-International Sci. J."},{"issue":"1","key":"11420_CR54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/1028415X.2000.11747303","volume":"3","author":"R Cade","year":"2000","unstructured":"Cade, R. et al. Autism and schizophrenia: Intestinal disorders. Nutr. Neurosci. 3 (1), 57\u201372 (2000).","journal-title":"Nutr. Neurosci."},{"issue":"10","key":"11420_CR55","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1038\/ajg.2012.211","volume":"107","author":"DA Leffler","year":"2012","unstructured":"Leffler, D. A. et al. A randomized, double-blind study of Larazotide acetate to prevent the activation of Celiac disease during gluten challenge. Am. J. Gastroenterol. 107 (10), 1554\u20131562 (2012).","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"11420_CR56","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/1475-6773.12007","volume":"48","author":"KA Kyanko","year":"2013","unstructured":"Kyanko, K. A., Curry, L. A. & Busch, S. H. Out-of-network physicians: how prevalent are involuntary use and cost transparency? Health Serv. Res. 48 (3), 1154\u20131172 (2013).","journal-title":"Health Serv. Res."},{"issue":"3","key":"11420_CR57","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.mehy.2012.11.044","volume":"80","author":"CA Heberling","year":"2013","unstructured":"Heberling, C. A., Dhurjati, P. S. & Sasser, M. Hypothesis for a systems connectivity model of autism spectrum disorder pathogenesis: links to gut bacteria, oxidative stress, and intestinal permeability. Med. Hypotheses. 80 (3), 264\u2013270. https:\/\/doi.org\/10.1016\/j.mehy.2012.11.044 (2013).","journal-title":"Med. Hypotheses"},{"issue":"2","key":"11420_CR58","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1542\/peds.2008-2933","volume":"124","author":"SH Ibrahim","year":"2009","unstructured":"Ibrahim, S. H., Voigt, R. G., Katusic, S. K., Weaver, A. L. & Barbaresi, W. J. Incidence of gastrointestinal symptoms in children with autism: a population-based study. Pediatrics 124 (2), 680\u2013686 (2009).","journal-title":"Pediatrics"},{"key":"11420_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-230X-11-22","volume":"11","author":"JB Adams","year":"2011","unstructured":"Adams, J. B., Johansen, L. J., Powell, L. D., Quig, D. & Rubin, R. A. Gastrointestinal flora and Gastrointestinal status in children with autism\u2013comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 11, 22 (2011).","journal-title":"BMC Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11420-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11420-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11420-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:09:43Z","timestamp":1758884983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11420-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11420"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11420-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article Hassan Mohammed Sonbol was incorrectly affiliated with Affiliation 2. The correct Affiliation for Hassan Mohammed Sonbol is \u2018Psychiatry Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt\u2019. The original Article has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study strictly adhered to the guidelines and regulations stipulated in the Declaration of Helsinki (DoH-Oct2008). Official authorization and permission to conduct the research were carefully secured from the Research Ethics Committee at the Faculty of Medicine, Mansoura University, Egypt (IRB\/0000023.05.2173). Prior to participation, each participant received a comprehensive explanation of the study\u2019s objectives and provided their informed written consent. Participants were assured of their right to decline participation or withdraw at any moment. The data\u2019s confidentiality and the study participants\u2019 anonymity were preserved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"27802"}}